These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory. Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL. J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444 [Abstract] [Full Text] [Related]
4. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET. Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang ZJ, Zhu ZH, Bao XJ, Wang RZ. Int J Mol Sci; 2016 Oct 18; 17(10):. PubMed ID: 27763550 [Abstract] [Full Text] [Related]
8. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort. Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Campion JY, Michels PE, Delrieu J, Lebouvier T, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MS, Gissot V, El-Hage W, Camus V, Gohier B, Desmidt T, MEMENTO study group. Am J Geriatr Psychiatry; 2024 Jun 18; 32(6):665-677. PubMed ID: 37973486 [Abstract] [Full Text] [Related]
9. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment. Nishi H, Sawamoto N, Namiki C, Yoshida H, Dinh HD, Ishizu K, Hashikawa K, Fukuyama H. J Neuroimaging; 2010 Jan 18; 20(1):29-36. PubMed ID: 19018949 [Abstract] [Full Text] [Related]
10. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Yoshizawa H, Gazes Y, Stern Y, Miyata Y, Uchiyama S. Psychiatry Res; 2014 Jan 30; 221(1):78-85. PubMed ID: 24262800 [Abstract] [Full Text] [Related]
13. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease. Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J. Clin EEG Neurosci; 2011 Apr 30; 42(2):71-6. PubMed ID: 21675596 [Abstract] [Full Text] [Related]
16. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG. Kim JH, Kim JH, Son YD, Joo YH, Lee SY, Kim HK, Woo MK. Schizophr Res; 2017 Apr 30; 182():55-65. PubMed ID: 27760700 [Abstract] [Full Text] [Related]
17. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, Okonkwo OC, La Rue A, Hermann BP, Koscik RL, Jonaitis EM, Sager MA, Asthana S. JAMA Neurol; 2015 Sep 30; 72(9):1013-20. PubMed ID: 26214150 [Abstract] [Full Text] [Related]
18. Exploring ASL perfusion MRI as a substitutive modality for 18F-FDG PET in determining the laterality of mesial temporal lobe epilepsy. Rahimzadeh H, Kamkar H, Ghafarian P, Hoseini-Tabatabaei N, Mohammadi-Mobarakeh N, Mehvari-Habibabadi J, Hashemi-Fesharaki SS, Nazem-Zadeh MR. Neurol Sci; 2024 May 30; 45(5):2223-2243. PubMed ID: 37994963 [Abstract] [Full Text] [Related]